|
IPPK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7508599999938E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.64029999999827E-05 |
| Normal-vs-Stage2 |
1.977670E-02 |
| Normal-vs-Stage3 |
4.49249999999735E-05 |
| Normal-vs-Stage4 |
4.16320000029557E-07 |
| Stage1-vs-Stage2 |
4.762800E-01 |
| Stage1-vs-Stage3 |
2.247200E-01 |
| Stage1-vs-Stage4 |
1.935760E-02 |
| Stage2-vs-Stage3 |
1.955640E-01 |
| Stage2-vs-Stage4 |
3.100500E-02 |
| Stage3-vs-Stage4 |
2.615200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.82210000000605E-05 |
| Normal-vs-AfricanAmerican |
3.376000E-02 |
| Normal-vs-Asian |
3.020600E-04 |
| Caucasian-vs-AfricanAmerican |
5.291200E-01 |
| Caucasian-vs-Asian |
8.658800E-01 |
| AfricanAmerican-vs-Asian |
4.887000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.6829000005234E-07 |
| Normal-vs-Female |
1.205830E-04 |
| Male-vs-Female |
7.945600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.13600000000303E-05 |
| Normal-vs-Age(41-60Yrs) |
2.28279999999748E-05 |
| Normal-vs-Age(61-80Yrs) |
5.87349999999764E-05 |
| Normal-vs-Age(81-100Yrs) |
2.322400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.633000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.162800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.166400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.887800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.613400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.692000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.615500E-02 |
| Classical-VS-Follicular |
3.196200E-01 |
| Classical-VS-Other |
1.101050E-01 |
| Classical-VS-Normal |
3.985100E-04 |
| Tall-VS-Follicular |
1.718040E-01 |
| Tall-VS-Other |
6.419000E-01 |
| Tall-VS-Normal |
1.74688999999839E-05 |
| Follicular-VS-Other |
2.452800E-01 |
| Follicular-VS-Normal |
3.367000E-04 |
| Other-VS-Normal |
1.938830E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.569560E-04 |
| Normal-vs-N1 |
5.1415000001942E-07 |
| N0-vs-N1 |
2.317500E-02 |
|
|
